301 related articles for article (PubMed ID: 26043786)
1. Efficacy and Safety of Long-Term Imatinib Therapy for Pulmonary Arterial Hypertension.
Speich R; Ulrich S; Domenighetti G; Huber LC; Fischler M; Treder U; Breitenstein A
Respiration; 2015; 89(6):515-24. PubMed ID: 26043786
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Matsubara H
Respir Med; 2017 Oct; 131():215-219. PubMed ID: 28947033
[TBL] [Abstract][Full Text] [Related]
3. Right Atrial Function in Pulmonary Arterial Hypertension.
Querejeta Roca G; Campbell P; Claggett B; Solomon SD; Shah AM
Circ Cardiovasc Imaging; 2015 Nov; 8(11):e003521; discussion e003521. PubMed ID: 26514759
[TBL] [Abstract][Full Text] [Related]
4. Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study.
Hoeper MM; Barst RJ; Bourge RC; Feldman J; Frost AE; Galié N; Gómez-Sánchez MA; Grimminger F; Grünig E; Hassoun PM; Morrell NW; Peacock AJ; Satoh T; Simonneau G; Tapson VF; Torres F; Lawrence D; Quinn DA; Ghofrani HA
Circulation; 2013 Mar; 127(10):1128-38. PubMed ID: 23403476
[TBL] [Abstract][Full Text] [Related]
5. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
6. Long-term safety and efficacy of imatinib in pulmonary arterial hypertension.
Frost AE; Barst RJ; Hoeper MM; Chang HJ; Frantz RP; Fukumoto Y; Galié N; Hassoun PM; Klose H; Matsubara H; Morrell NW; Peacock AJ; Pfeifer M; Simonneau G; Tapson VF; Torres F; Dario Vizza C; Lawrence D; Yang W; Felser JM; Quinn DA; Ghofrani HA
J Heart Lung Transplant; 2015 Nov; 34(11):1366-75. PubMed ID: 26210752
[TBL] [Abstract][Full Text] [Related]
7. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Pericardial Effusion on Serial Echocardiograms in Pulmonary Arterial Hypertension.
Batal O; Dardari Z; Costabile C; Gorcsan J; Arena VC; Mathier MA
Echocardiography; 2015 Oct; 32(10):1471-6. PubMed ID: 25682779
[TBL] [Abstract][Full Text] [Related]
9. Imatinib mesylate for the treatment of pulmonary arterial hypertension.
ten Freyhaus H; Dumitrescu D; Berghausen E; Vantler M; Caglayan E; Rosenkranz S
Expert Opin Investig Drugs; 2012 Jan; 21(1):119-34. PubMed ID: 22074410
[TBL] [Abstract][Full Text] [Related]
10. Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.
Grapsa J; Pereira Nunes MC; Tan TC; Cabrita IZ; Coulter T; Smith BC; Dawson D; Gibbs JS; Nihoyannopoulos P
Circ Cardiovasc Imaging; 2015 Jun; 8(6):. PubMed ID: 26063743
[TBL] [Abstract][Full Text] [Related]
11. [Long-term effects with ambrisentan monotherapy in patients with pulmonary arterial hypertension].
Wen L; Jiang X; An P; He J; Zheng L; Liu Q; Peng F; Xu X; Jing Z
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):469-73. PubMed ID: 25164219
[TBL] [Abstract][Full Text] [Related]
12. Long-term trial of bosentan monotherapy for pulmonary arterial hypertension in Japanese patients.
Sasayama S; Satoh T; Izumi T; Yoshida S; Kyotani S; Tahara N
Curr Med Res Opin; 2007 Feb; 23(2):395-400. PubMed ID: 17288693
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome of systemic sclerosis-associated pulmonary arterial hypertension treated with bosentan as first-line monotherapy followed or not by the addition of prostanoids or sildenafil.
Launay D; Sitbon O; Le Pavec J; Savale L; Tchérakian C; Yaïci A; Achouh L; Parent F; Jais X; Simonneau G; Humbert M
Rheumatology (Oxford); 2010 Mar; 49(3):490-500. PubMed ID: 20015974
[TBL] [Abstract][Full Text] [Related]
14. Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan.
Benza RL; Rayburn BK; Tallaj JA; Pamboukian SV; Bourge RC
Chest; 2008 Jul; 134(1):139-45. PubMed ID: 18403673
[TBL] [Abstract][Full Text] [Related]
15. Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Marra AM; Egenlauf B; Ehlken N; Fischer C; Eichstaedt C; Nagel C; Bossone E; Cittadini A; Halank M; Gall H; Olsson KM; Lange TJ; Grünig E
Int J Cardiol; 2015 Sep; 195():19-26. PubMed ID: 26011408
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of sildenafil as a rescue therapy for patients with severe pulmonary arterial hypertension and given long-term treatment with prostanoids: 2-year experience.
Ruiz MJ; Escribano P; Delgado JF; Jiménez C; Tello R; Gómez MA; de la Calzada CS
J Heart Lung Transplant; 2006 Nov; 25(11):1353-7. PubMed ID: 17097500
[TBL] [Abstract][Full Text] [Related]
17. Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension.
Speich R; Treder U; Domenighetti G; Huber LC; Ulrich S
Int J Clin Pharm; 2014 Apr; 36(2):256-60. PubMed ID: 24287663
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of imatinib mesylate in the treatment of pulmonary arterial hypertension.
Chhina MK; Nargues W; Grant GM; Nathan SD
Future Cardiol; 2010 Jan; 6(1):19-35. PubMed ID: 20014985
[TBL] [Abstract][Full Text] [Related]
19. Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension.
Vizza CD; Letizia C; Petramala L; Badagliacca R; Poscia R; Zepponi E; Crescenzi E; Nona A; Benedetti G; Ferrante F; Sciomer S; Fedele F
Regul Pept; 2008 Nov; 151(1-3):48-53. PubMed ID: 18796317
[TBL] [Abstract][Full Text] [Related]
20. Continuous hemodynamic monitoring in patients with pulmonary arterial hypertension.
Frantz RP; Benza RL; Kjellström B; Bourge RC; Barst RJ; Bennett TD; McGoon MD
J Heart Lung Transplant; 2008 Jul; 27(7):780-8. PubMed ID: 18582809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
